NCT02622945

Brief Summary

This study aims to determine whether transcranial direct current stimulation (tDCS) paired with speech-language therapy is more beneficial than speech-language therapy alone in acute and chronic post-stroke aphasia.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 7, 2015

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

November 26, 2018

Status Verified

November 1, 2018

Enrollment Period

6.3 years

First QC Date

November 17, 2015

Last Update Submit

November 21, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in picture naming scores in trained and untrained items

    Before and after 15 sessions of intervention (3 weeks) and at 2 weeks and 2 months follow-ups

Secondary Outcomes (4)

  • Change in Philadelphia Naming Test: Picture naming of everyday objects, different from training set

    Before and after 15 sessions of intervention (3 weeks) and at 2 weeks and 2 months follow-ups

  • Change in Written naming of objects and actions

    Before and after 15 sessions of intervention (3 weeks) and at 2 weeks and 2 months follow-ups

  • Change in working memory (digit span)

    Before and after 15 sessions of intervention (3 weeks) and at 2 weeks and 2 months follow-ups

  • Change in verbal fluency

    Before and after 15 sessions of intervention (3 weeks) and at 2 weeks and 2 months follow-ups

Study Arms (2)

Active tDCS plus Speech-Language Therapy

EXPERIMENTAL

Active tDCS will be applied at the beginning of 45min speech-language therapy session and will last for 20 min. Language therapy will be oral and written naming. This is a cross-over study so all participants will receive this arm but the order will be randomized.

Device: Active tDCS plus Speech-Language Therapy

Sham plus Speech-Language Therapy

SHAM COMPARATOR

Sham tDCS will be applied at the beginning of 45min speech-language therapy session. Language therapy will be oral and written naming. This is a cross-over study so all participants will receive this arm but the order will be randomized.

Device: Sham plus Speech-Language Therapy

Interventions

Stimulation will be delivered by a battery-driven constant current stimulator. The electrical current will be administered to a pre-specified region of the brain not affected by the lesion(perilesional areas, right hemisphere or cerebellum). The stimulation will be delivered at an intensity of 2mA (estimated current density 0.04 mA/cm2; estimated total charge 0.048C/cm2) in a ramp-like fashion for a maximum of 20 minutes. Speech-language therapy will be oral and written naming.

Also known as: Active tDCS and speech-therapy
Active tDCS plus Speech-Language Therapy

Speech-Language therapy will be administered during sham stimulation. Current will be administered in a ramp-line fashion but after the ramping the intensity will drop to 0 mA. Speech-language therapy will be oral and written naming.

Also known as: Sham tDCS plus speech-therapy
Sham plus Speech-Language Therapy

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically diagnosed with with post-stroke aphasia and word-retrieval deficits
  • Premorbid speakers of English
  • Diagnosis will be based on neuropsychological testing, language testing (most commonly the Western Aphasia Battery), MRI and clinical assessment
  • Stroke size: any l
  • Location: Left hemisphere strokes only from any etiology.
  • Time since stroke onset: 1 day to 20 years.

You may not qualify if:

  • uncorrected visual or hearing impairment by self report
  • other premorbid neurological disorder affecting the brain
  • any other language-based learning disorder or other neurodegenerative disorder such as Alzheimer's Disease or Primary Progressive Aphasia
  • premorbidly diagnosed with a developmental language disorder
  • Pregnant women will also be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Medicine

Baltimore, Maryland, 21287, United States

Location

Related Publications (2)

  • Schlaug G, Marchina S, Wan CY. The use of non-invasive brain stimulation techniques to facilitate recovery from post-stroke aphasia. Neuropsychol Rev. 2011 Sep;21(3):288-301. doi: 10.1007/s11065-011-9181-y. Epub 2011 Aug 14.

    PMID: 21842404BACKGROUND
  • Dmochowski JP, Datta A, Huang Y, Richardson JD, Bikson M, Fridriksson J, Parra LC. Targeted transcranial direct current stimulation for rehabilitation after stroke. Neuroimage. 2013 Jul 15;75:12-19. doi: 10.1016/j.neuroimage.2013.02.049. Epub 2013 Mar 5.

    PMID: 23473936BACKGROUND

MeSH Terms

Conditions

Aphasia

Interventions

Speech Therapy

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Rehabilitation of Speech and Language DisordersRehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2015

First Posted

December 7, 2015

Study Start

February 1, 2014

Primary Completion

June 1, 2020

Study Completion

June 1, 2020

Last Updated

November 26, 2018

Record last verified: 2018-11

Locations